title: Macroprolactinemia in hyperprolactinemic infertile women.
abstract: Hyperprolactinemia occurs in 15-20 % of women with menstrual disturbances and 30-40 % of infertile women and it can adversely affect the fertility. High molecular weight prolactin (macroprolactin) has long been known in hyperprolactinemic fertile women. However, the prevalence of macroprolactinemia in hyperprolactinemic infertile women is not known. This cross-sectional study was carried out during the period of June 2010 and June 2011 at a single tertiary care centre. All women who attended the infertility clinic during this period were screened for hyperprolactinemia and only women with hyperprolactinemia and infertility were further studied for the presence of macroprolactin by polyethylene glycol precipitation assay. We compared the clinical, hormonal profile and fertility outcome of infertile women with true hyperprolactinemia and macroprolacinemia using appropriate statistical tests. Of 1,163 infertile women, 183 (15.7 %) had hyperprolactinemia [134 (73 %) had primary infertility and 49 (27 %) had secondary infertility]. Out of these 183 women with hyperprolactinemia, one had microadenoma, 161 had true idiopathic hyperprolactinemia and 21 (11.5 %) women had macroprolactinemia. The prevalence of oligomenorrhea and galactorrhea were significantly higher in patients with true hyperprolactinemia than macroprolactinemia (46 vs. 14 %, p < 0.008 and 30 vs. 5 %, p = 0.01 respectively). Twenty-two patients (13.5 %) of true hyperprolactinemia and two (9 %) in macroprolactinemia became pregnant during the study period. Prolactin measurement should be a part of routine evaluation of couples referred to infertility clinics. Macroprolactin screening is mandatory when clinical features and serum PRL assay results are conflicting. Patients with macroprolactinemia should be investigated for causes of infertility other than hyperprolactinemia.
authors.affiliation: Department of Obstetrics and Gynecology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
authors.forename: Krithika
authors.initials: K
authors.lastname: Thirunavakkarasu
authors.forename: Pinaki
authors.initials: P
authors.lastname: Dutta
authors.forename: Subbiah
authors.initials: S
authors.lastname: Sridhar
authors.forename: Lakhbir
authors.initials: L
authors.lastname: Dhaliwal
authors.forename: G R V
authors.initials: GR
authors.lastname: Prashad
authors.forename: Shalini
authors.initials: S
authors.lastname: Gainder
authors.forename: Naresh
authors.initials: N
authors.lastname: Sachdeva
authors.forename: Anil
authors.initials: A
authors.lastname: Bhansali
mesh_terms: D000328:Adult; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood* / Q000150:complications; D007247:Infertility, Female / Q000097:blood* / Q000150:complications; D011388:Prolactin / Q000097:blood*
chemical_list: C060678:prolactin, polymeric; D011388:Prolactin
references.citation: J Clin Endocrinol Metab. 2001 Jun;86(6):2743-6
references.pmid: 11397880
references.citation: J Clin Endocrinol Metab. 1992 Nov;75(5):1226-9
references.pmid: 1430082
references.citation: Clin Endocrinol (Oxf). 2006 Feb;64(2):226
references.pmid: 16430726
references.citation: Eur J Clin Invest. 2007 Jul;37(7):552-7
references.pmid: 17576206
references.citation: J Clin Endocrinol Metab. 2002 Feb;87(2):581-8
references.pmid: 11836289
references.citation: Endocrine. 2012 Feb;41(1):138-43
references.pmid: 21959531
references.citation: J Clin Endocrinol Metab. 1997 Sep;82(9):3107-10
references.pmid: 9284753
references.citation: Fertil Steril. 2008 Nov;90(5 Suppl):S60
references.pmid: 19007647
references.citation: Clin Endocrinol (Oxf). 2006 Aug;65(2):265-73
references.pmid: 16886971
references.citation: Clin Endocrinol (Oxf). 1999 Jul;51(1):119-26
references.pmid: 10468974
references.citation: Endocrinol Metab Clin North Am. 2008 Mar;37(1):67-99, viii
references.pmid: 18226731
references.citation: Fertil Steril. 1987 May;47(5):785-91
references.pmid: 3569555
references.citation: Endocrine. 2012 Apr;41(2):327-33
references.pmid: 22187359
references.citation: Clin Chem. 1998 Aug;44(8 Pt 1):1758-9
references.pmid: 9702971
references.citation: Scand J Clin Lab Invest. 1995 Apr;55(2):139-47
references.pmid: 7667607
references.citation: Endocr Pract. 2006 May-Jun;12(3):275-80
references.pmid: 16772199
references.citation: J Clin Endocrinol Metab. 2002 Dec;87(12):5410-5
references.pmid: 12466327
references.citation: Endocrine. 2012 Apr;41(2):169-70
references.pmid: 22286912
references.citation: Am J Obstet Gynecol. 1981 Feb 1;139(3):264-7
references.pmid: 7468693
references.citation: Ann Clin Biochem. 1997 May;34 ( Pt 3):252-8
references.pmid: 9158821
references.citation: J Clin Endocrinol Metab. 1974 Nov;39(5):928-35
references.pmid: 4213557
references.citation: Clin Chem. 2000 Dec;46(12):1993-5
references.pmid: 11106334
references.citation: Clin Endocrinol (Oxf). 1992 Oct;37(4):365-72
references.pmid: 1483294